Clinical Trials Browser

Completed × Transurethral Resection of Bladder × 30 days × Clear all

NCT02710734 2026-05-22

Risk Enabled Therapy After Initiating Neoadjuvant Chemotherapy for Bladder Cancer (RETAIN)

Phase 2 Completed

Urothelial Carcinoma of the Bladder